Medicare Enrolled

Dr. Cedric Spak, MD

Infectious Disease · Fort Worth, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
1025 COLLEGE AVE, Fort Worth, TX 76104
8178109810
Registered in NPPES since 2006
NPI: 1063575199 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Spak from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Spak? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Spak

Dr. Cedric Spak is an infectious disease specialist in Fort Worth, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Spak performed 14,840 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Spak received a total of $397,926 from 34 pharmaceutical and/or device companies across 715 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Spak is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration ▲ Top 5% volume in TX $397,926 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
14,840
Medicare services
Top 5% in TX for infectious disease
Not available
Unique patients (not deduplicated)
$24
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Dalbavancin injection, 5 mg
An injection of the antibiotic dalbavancin, administered in a 5 mg dose.
11,100 $12 $43
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
884 $62 $250
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
671 $50 $160
Ertapenem sodium injection, 500 mg
An injection of ertapenem sodium, an antibiotic medication, administered at a dose of 500 mg.
504 $10 $328
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
479 $93 $227
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
362 $96 $225
Additional hour of intravenous infusion
This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis.
331 $16 $50
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
127 $102 $297
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
94 $136 $434
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
62 $66 $148
Blood draw from central venous catheter
A procedure to collect a blood sample directly from a central venous tube or catheter.
51 $23 $55
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
42 $128 $349
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
40 $39 $89
Infusion tube insertion with imaging guidance
A radiologist inserts an infusion tube into the body while using imaging guidance to ensure proper placement and reviews the procedure.
28 $302 $600
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
27 $140 $304
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
20 $18 $60
New patient office visit, complex (60-74 min) 18 $162 $438
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
7.3% high complexity
78.2% medium
14.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$397,926
Total received (2018-2024)
Avg $56,847/year across 7 years
Top 2% in TX for infectious disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
715
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$44,462
2023
$142,486
2022
$14,070
2021
$20,036
2020
$46,848
2019
$70,872
2018
$59,152

Payments by company (2024)

Takeda Pharmaceuticals U.S.A., Inc.
$29,139
Shionogi Inc
$6,461
Invivyd Inc
$3,695
ABBVIE INC.
$3,112
Astellas Pharma US Inc
$1,572
Insmed, Inc.
$241
Paratek Pharmaceuticals, Inc.
$59
Eurofins Viracor, LLC
$46
La Jolla Pharmaceutical Company
$41
Melinta Therapeutics, LLC
$41
ViiV Healthcare Company
$32
KAMADA LTD.
$25
Top 3 companies account for 88.4% of 2024 payments
All-time payments by company (2018-2024) ›
Takeda Pharmaceuticals U.S.A., Inc.
$138,893
Astellas Pharma US Inc
$53,504
Allergan Inc.
$45,008
Genentech USA, Inc.
$43,343
Merck Sharp & Dohme Corporation
$21,441
Insmed, Inc.
$21,139
Shionogi Inc
$18,375
Allergan, Inc.
$11,502
Melinta Therapeutics, LLC
$7,438
ABBVIE INC.
$6,226
AbbVie Inc.
$6,204
BioFire Diagnostics, LLC
$6,000
Merck Sharp & Dohme LLC
$5,738
Invivyd Inc
$3,695
Melinta Therapeutics, Inc.
$3,509
Theratechnologies Inc.
$2,537
CIPLA USA INC.
$1,095
Abbott Laboratories
$417
ViiV Healthcare Company
$384
KAMADA LTD.
$313
Janssen Biotech, Inc.
$192
Cumberland Pharmaceuticals, Inc.
$192
Gilead Sciences, Inc.
$180
Paratek Pharmaceuticals, Inc.
$154
Access Pro Medical, LLC
$113
La Jolla Pharmaceutical Company
$83
TETRAPHASE PHARMACEUTICALS, INC.
$56
Novartis Pharmaceuticals Corporation
$50
Eurofins Viracor, LLC
$46
Octapharma USA, Inc.
$30
Janssen Products, LP
$20
Veloxis Pharmaceuticals, Inc.
$18
Dynavax Technologies Corporation
$14
Nabriva Therapeutics, plc
$14
Top 3 companies account for 59.7% of all-time payments
Associated products mentioned in payments ›
2ND GEN CENTRIMAG PRIMARY CONSOLE · AMBISOME · AVYCAZ · Arikayce · Baxdela · BioFire FilmArray · CABENUVA · CRESEMBA · CYTOGAM · Cresemba · DALVANCE · DIFICID · DOVATO · Envarsus XR (SP) · Fetroja · HeartMate · Heplisav-B · ISENTRESS · Kimyrsa · LIVTENCITY · MYCAMINE · Matriderm · NUZYRA · Orbactiv · PANZYGA · PEMGARDA · PIFELTRO · PREZCOBIX · RECARBRIO · Rezzayo · SYMTUZA · Symtuza · TEFLARO · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TROGARZO · VIBATIV · Vabomere · Vibativ · XERAVA · Xenleta · Xerava · Xofluza · ZEMDRI (PLAZOMICIN) · ZERBAXA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an infectious disease specialist in Fort Worth?
Compare infectious diseases in the Fort Worth area by procedure volume, costs, and industry payment transparency.
Browse infectious diseases nearby

Geographic Context

Infectious diseases in nearby ZIP areas
51
County median income
$81,905
Nearest hospital to ZIP centroid (approximate)
JPS HEALTH NETWORK
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Spak is a mixed practice specialist, with above-average Medicare volume (top 5% in TX), with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Spak experienced with dalbavancin injection, 5 mg?
Based on Medicare claims data, Dr. Spak performed 11,100 dalbavancin injection, 5 mg services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Spak receive payments from pharmaceutical companies?
Yes. Dr. Spak received a total of $397,926 from 34 companies across 715 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Spak's costs compare to other infectious diseases in Fort Worth?
Dr. Spak's average Medicare payment per service is $24. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Spak) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →